bavencio
Pharmaranks rates Bavencio 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Bavencio (Avelumab) is a programmed death ligand-1 blocker used to treat Transitional Cell Carcinoma, Merkel Cell Carcinoma.
Avelumab · by Emd Serono
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Avelumab
- Drug class
- Programmed Death Ligand-1 Blocker
- Form
- Injectable
- Strength
- Avelumab 20MG/ML
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Emd Serono
- FDA application
- BLA761049
Storing Bavencio, and how long it keeps
Quoted from this product’s own FDA label. Storage belongs to the product and its device, not to the drug in general — a pen and a tablet of the same medicine are kept completely differently.
- “of diluted BAVENCIO solution Protect from light.”
- “Store diluted BAVENCIO solution: At room temperature up to 77°F (25°C) for no more than 4 hours from the time of dilution.”
Drug class
May treat (source: NIH RxClass)
See how Bavencio ranks — best-rated programmed death ligand-1 blocker for:
Dosage forms
Injectable
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Bavencio treat?
- Bavencio (Avelumab) may be used to treat transitional cell carcinoma, merkel cell carcinoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Bavencio rated?
- pharmaranks gives Bavencio a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Bavencio?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Bavencio. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Bavencio?
- Bavencio is marketed by Emd Serono. You can see Emd Serono's full profile, rating, and other products on pharmaranks.
- Is Bavencio a brand-name or generic drug?
- Bavencio is a brand-name product with the active ingredient Avelumab.
- Is Bavencio available over the counter?
- No. Bavencio is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Bavencio come in?
- Bavencio is currently marketed as injectable, per the FDA's National Drug Code Directory.
- What class of drug is Bavencio?
- Bavencio is classified as programmed death ligand-1 blocker, per the FDA's Established Pharmacologic Class.
- Is Bavencio FDA-registered?
- Bavencio is on record with the U.S. FDA under application number BLA761049. You can verify this on its official FDA label.
- Has Bavencio been recalled by the FDA?
- Bavencio has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Bavencio safe?
- There's no single safe-or-not verdict. pharmaranks gives Bavencio a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about AVELUMAB
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 2,239 reports naming AVELUMAB — the active ingredient in Bavencio, and the FDA flagged 96% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- neoplasm progression94 reports
- diarrhoea92 reports
- fatigue80 reports
- nausea79 reports
- pyrexia79 reports
- pneumonitis68 reports
- acute kidney injury66 reports
- general physical health deterioration63 reports
Read these as a signal, not a rate. A report does not mean AVELUMAB caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Bavencio head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
bavencio
70/100